

Catalog illustration. Actual packaging and lot details are confirmed on inquiry.
Tirzepatide 20 mg
- Per vial
- 20 mg
- Per box
- 10 vials
- Product code
- TR20
Tirzepatide 20 mg is listed at 20 mg per vial, 10 vials per box, under product code TR20. It is one of 11 Tirzepatide presentations in the catalog, which range from 5 mg to 120 mg per vial. Tirzepatide is a 39-amino-acid synthetic peptide that activates both the GIP and GLP-1 receptors, used in laboratory research on incretin pharmacology.
Compare presentations
Each option opens its own specification. Availability is confirmed on inquiry.
Let’s put your request together.
Ask for this material’s price, or use + to include it in a combined inquiry.
Presentation: 20 mg per vial, 10 vials/box
Minimum quantity: 1 · Availability confirmed on inquiry
No payment is taken here. Confirm specifications, quantities and shipping with our team on WhatsApp.
| Product code | TR20 |
|---|---|
| Supplier presentation | 20 mg per vial, 10 vials/box |
| Intended use | Laboratory research only |
Catalog fields are general product information. Confirm the actual label, current lot specification and available documents before relying on a value for procurement or research planning.
Research Use Only. This product is intended strictly for laboratory research. It is not a drug, supplement or medical product and is not for human or veterinary consumption.
About Tirzepatide
Tirzepatide is a 39-amino-acid synthetic peptide whose sequence is based on glucose-dependent insulinotropic polypeptide (GIP). It activates both the GIP receptor and the glucagon-like peptide-1 (GLP-1) receptor, which is why it is described as a dual incretin receptor agonist.
Tirzepatide is also the active ingredient of licensed pharmaceutical products in some markets. The material listed here is supplied for laboratory research only; it is not a pharmaceutical product and must not be used as one.
What to confirm for Tirzepatide
Check these points with our team before you order:
- The amount per vial you need. Each fill is a separate listing with its own product code, so a concentration-response design may call for more than one.
- The counter-ion and net peptide content stated on the lot documents, which determine how much peptide a vial actually contains.
- The number of boxes you need and the US delivery destination.
- Which lot documents you require before ordering, such as an identity or purity report.
Related research materials
- Semaglutide →Long-acting, fatty-acid-modified GLP-1 receptor agonist peptide.
- Retatrutide →Investigational triple agonist of the GIP, GLP-1 and glucagon receptors.
- Cagrilintide →Long-acting acylated analogue of the pancreatic hormone amylin.
- Mazdutide →Oxyntomodulin-based dual agonist of the GLP-1 and glucagon receptors.
- Survodutide →Investigational dual agonist of the glucagon and GLP-1 receptors.
- Liraglutide →Acylated GLP-1 receptor agonist with a C16 fatty-acid side chain.


